Crossmark

Best practices for reporting throughput in biomedical research

Crossref DOI link: https://doi.org/10.1038/s41592-022-01483-6

Published Online: 2022-05-04

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Herbig, Maik https://orcid.org/0000-0001-7592-7829
Isozaki, Akihiro https://orcid.org/0000-0003-0391-9832
Di Carlo, Dino https://orcid.org/0000-0003-3942-4284
Guck, Jochen https://orcid.org/0000-0002-1453-6119
Nitta, Nao https://orcid.org/0000-0002-9093-9016
Damoiseaux, Robert

Kamikawaji, Shogo

Suyama, Eigo

Shintaku, Hirofumi https://orcid.org/0000-0002-9972-4222
Wu, Angela Ruohao https://orcid.org/0000-0002-3531-4830
Nikaido, Itoshi

Goda, Keisuke https://orcid.org/0000-0001-6302-6038
License Information

Text and Data Mining valid from 2022-05-04

Version of Record valid from 2022-05-04
More Information

Article History

First Online: 4 May 2022

Competing interests

: K.G. and N.N. are shareholders of CYBO. All remaining authors declare no competing interests.